Treatments for Anxiety: Meditation and Escitalopram

ClinicalTrials.gov ID: NCT03522844

Public ClinicalTrials.gov record NCT03522844. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 22, 2026, 6:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Comparative Effectiveness of Mindfulness-Based Stress Reduction and Pharmacotherapy for Anxiety

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

We propose the first randomized, controlled study to assess the comparative effectiveness of Mindfulness-Based Stress Reduction (MBSR) with a medication for anxiety disorders. We will use escitalopram, gold-standard SSRI treatment for patients with anxiety disorders, and will examine the comparative effectiveness of the two treatments on anxiety symptoms and other outcomes important to patients.

Study identification

NCT ID: NCT03522844
Recruitment status: Completed
Study type: Interventional
Phase: Phase 4
Lead sponsor: Georgetown University; Other
Enrollment: 276 participants

Conditions and interventions

Conditions

Interventions

Mindfulness-Based Stress Reduction Other
Escitalopram Drug

Other · Drug

Eligibility (public fields only)

Age range: 18 Years to 75 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 18, 2018 (Actual)
Primary completion: Oct 31, 2021 (Actual)
Completion: Jan 5, 2022 (Actual)
Last update posted: Jan 11, 2022

2018 – 2022

United States locations

U.S. sites: 3
U.S. states: 3
U.S. cities: 3

Facility	City	State	ZIP	Site status
Georgetown University Medical Center	Washington D.C.	District of Columbia	20007	—
Massachusetts General Hospital	Boston	Massachusetts	02114	—
New York University	New York	New York	10016	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT03522844, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 11, 2022 · Synced Oct 22, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03522844 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →